BNN Offers Regulatory Expertise in Health Products Containing Nanotechnology for EU projects

At BNN, we are happiest when we can cross-pollinate from different projects we are involved in. On 29 October 2024, the consortium from two of our EU-funded projects, PHOENIX-OITB and NABIHEAL, came together online and in Barcelona at the CSIC – Residència d´investigadors facilities for a joint internal workshop on regulatory affairs.

The workshop focused on the regulatory framework for health products containing nanomaterials. The event provided a valuable opportunity to discuss with key stakeholders from our projects, as well as featured important contributions from BSI and the Nanotechnology Industries Association (NIA).

During the workshop, participants reviewed and discussed major regulatory processes and guidelines for the approval and commercialization of medical devices and medicinal products that incorporate nanoparticles. Furthermore, the applicability of additional guidelines for other nanomaterial-containing products, including chemicals, food, and cosmetics were also explored and presented.

BioNanoNet Association member Ivana Vinković Vrček of IMI co-organized the workshop with Sergio Veiga Herreros of ASPHALION. From BNN, Daniel García gave a key presentation on strategic regulatory components for health products containing nanotechnology to reach the EU market.